Delivery Order SPE2DB20D3103-SPE2DB25FQ0R6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $44,106.83 to AmerisourceBergen Drug Corp for 50 mg TANK ASEТМ kits on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract is structured as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4,886.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tankas 50 mg kits on July 24, 2025, with an ultimate completion date of July 25, 2025. This contract represents a non-competitive, non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $35,182.40 to AmerisourceBergen Drug Corp for Tank Ase 50 mg kits, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,327.64, is for the delivery of 4565320280 TNKASE 50 MG KITS and has an ultimate completion date of August 2, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,714.50 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price delivery order, issued under the contract number 4569181551, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. As a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $10,910.66 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract performance will take place at the vendor's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at the company's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $25,366.32 delivery order to AmerisourceBergen Drug Corp on August 23, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is a non-competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $24,907.53 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and will perform the work at its Corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,963.84 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued under contract number 4569048102, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0R6Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,729.86 firm fixed price delivery order for Tenkase 50 mg kits, with a completion date of August 29, 2025. This was a competitively awarded, non-set-aside contract with performance located at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceuticals and medical supplies to defense and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to compete successfully for and fulfill diverse medical supply needs across multiple therapeutic domains. This delivery order represents a routine fulfillment under the prime vendor contract, supporting DLA's mission to provide pharmaceutical commodities to military personnel and healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 8/28/25 |